INM

InMed Pharmaceuticals Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$255.56 sample

-1.70 (-0.66%) 1D

Market cap

$978.4B

Price as of

2026-10-15

Latest filing

8-K · 2026-08-27

Alerts

8

Price$255.56 +16.61% 3M daily closessample

257.44215.61

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider buy: Director
Oct 05INSInsider sell: 10% owner
Sep 28INSInsider sell: 10% owner
Sep 18INSInsider buy: Director
Sep 11INSInsider sell: Chief Executive Officer
Sep 04INSInsider buy: Director
Aug 27SECDEF 14A filed
Aug 21INSInsider sell: Chief Financial Officer

Sign up to see the real INM record →

Company facts

SEC EDGAR registration

Name: InMed Pharmaceuticals Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: +12sample, -100 to +100
Reporting currency: USD

Who is positioning in INM

sample

Insiders: 8 insider transactions over 90 days, net selling, $577.2M
Congress: No member trades over 90 days
Institutions · 13F: 11 funds hold $22.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$37.5B +9.7% y/y

Q4 2024Q3 2026

Inventory$23.4B +13.9% y/y

Q4 2024Q3 2026

Accounts receivable$16.9B +13.2% y/y

Q4 2024Q3 2026

Total debt$44.5B +7.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $907.8B -4.3% 3M
Sample peer B: $526.6B +3.8% 3M
Sample peer C: $774.8B -0.6% 3M
Sample peer D: $624.4B -4.6% 3M
Sample peer E: $667.3B +12.9% 3M